Skip to main content

Advertisement

SpringerLink
Log in

Occult hepatitis B in blood donors in Indonesia: altered antigenicity of the hepatitis B virus surface protein

  • Original Article
  • Published:
Hepatology International Aims and scope Submit manuscript

An Erratum to this article was published on 22 September 2010

Abstract

Background and aims

Occult hepatitis B virus infection (OBI) poses a challenge to the safety of blood donation. The prevalence of OBI is not well documented in Indonesia, although this information in such an endemic country is needed. This study was aimed to evaluate the prevalence of occult hepatitis B in blood donors from two cities of Indonesia, and to study the genetic variation and its effect on the predicted antigenicity of HBsAg.

Methods

Serum samples of 309 regular blood donors negative for HBsAg were tested for anti-HBs and anti-HBc. Hepatitis B virus (HBV) DNA isolated from anti-HBc-positive samples were analyzed by polymerase chain reaction, cloned and sequenced. Antigenic properties of identified HBsAg mutants were predicted by calculation of the antigenic index.

Results

Of the 309 HBsAg-negative samples, anti-HBc was positive in 134 (43.4%) and HBV DNA was detected in 25 (8.1%). Seven of the viremic samples had nucleotide substitutions (A521G, A551T, C582T, and A562G) in the S gene, causing amino acid mutations (T123A, M133L, and T143M) in the ‘a’ determinant of HBsAg that resulted in changes in the predicted antigenicity.

Conclusions

OBI was detected in blood donors’ samples in Indonesia. Anti-HBc was shown to be a better screening parameter than HBsAg, however, it might result in the loss of donors particularly in endemic countries. HBsAg detection failure in this study might be due to mutations altering the protein antigenicity and/or the low-level carriage of HBV.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. World Health Organization. Hepatitis B vaccines: weekly epidemiological record. WHO annual report. Switzerland; 2009, 84:405–420

  2. Liaw YF, Leung N, Kao JH, Piratvisuth T, Gane E, Han KH, Guan R, Lau GKK, Locarnini S. Asian–Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int 2008;2:263–283

    Article  PubMed  Google Scholar 

  3. Hoofnagle JH, Seeff LB, Bales ZB, Zimmerman HJ. Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N Engl J Med 1978;298:1379–1383

    Article  CAS  PubMed  Google Scholar 

  4. Levicnik-Stezinar S, Rahne-Potokar U, Candotti D, Lelie N, Allain JP. Anti-HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipients. J Hepatol 2008;48:1022–1025

    Article  PubMed  Google Scholar 

  5. Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M, Craxi A, Donato F, Ferrari C, Gaeta GB, Gerlich WH, Levrero M, Locarnini S, Michalak T, Mondelli MU, Pawlotsky JM, Pollicino T, Prati D, Puoti M, Samuel D, Shouval D, Smedile A, Squadrito G, Trepo C, Villa E, Will H, Zanetti AR, Zoulim F. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 2008;49:652–657

    Article  PubMed  Google Scholar 

  6. Allain JP. Occult hepatitis B virus infection: implications in transfusion. Vox Sang 2004;86:83–91

    Article  PubMed  Google Scholar 

  7. Torbenson M, Thomas DL. Occult hepatitis B. Lancet Infect Dis 2002;2:479–486

    Article  PubMed  Google Scholar 

  8. Manzini P, Girotto M, Borsotti R, Giachino O, Guaschino R, Lanteri M, Testa D, Ghiazza P, Vacchini M, Danielle F, Pizzi A, Valpreda C, Castagno F, Curti F, Magistroni P, Abate ML, Smedile A, Rizzetto M. Italian blood donors with anti-HBc and occult hepatitis B infection. Haematologica 2007;92:1664–1670

    Article  CAS  PubMed  Google Scholar 

  9. Chemin I, Trepo C. Clinical impact of occult HBV infections. J Clin Virol 2005;34(Suppl 1):S15–S21

    Article  PubMed  Google Scholar 

  10. Okamoto H, Yano K, Nozaki Y, Matsui A, Miyazaki H, Yamamoyo K, Tsuda F, Machida A, Mishiro S. Mutation within the S gene of hepatitis B virus transmitted from mothers to babies immunized with hepatitis B immunoglobulin and vaccine. Pediatric Res 1992;32:264–268

    Article  CAS  Google Scholar 

  11. Iizuka H, Ohmura K, Ishijima A, Satoh K, Tanaka T, Tsuda F, Okamoto H, Miyakawa Y, Mayumi M. Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBsAg. Vox Sang 1992;63:107–111

    Article  CAS  PubMed  Google Scholar 

  12. Okamoto H, Nishizawa T. Non-B Non-C Non-G hepatitis virus gene, polynucleotide, polypeptide, virion, method for separating virion, and method for detecting virus; 1992. http://www.freepatentsonline.com/EP1010759.html (with permission)

  13. Takahashi K, Akahane Y, Hino K, Ohta Y, Mishiro S. Hepatitis B virus genomic sequence in the circulation of hepatocellular carcinoma patients: comparative analysis of 40 full-length isolates. Arch Virol 1998;143:2313–2326

    Article  CAS  PubMed  Google Scholar 

  14. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989;339:237–238

    Article  CAS  PubMed  Google Scholar 

  15. Hall TA. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl Acids Symp 1999;41:95–98

    CAS  Google Scholar 

  16. Sastrosoewignjo RI, Omi S, Okamoto H, Mayumi M, Rustam M, Sujudi T. The complete nucleotide sequence of HBV DNA clone of subtype adw (pMND122) from Menado in Sulawesi Island, Indonesia. ICMR Ann 1987;7:51–60.

    Google Scholar 

  17. Mulyanto, Depamede SN, Surayah K, Tsuda F, Ichiyama K, Takahashi M, Okamoto H. A nationwide molecular epidemiological study on hepatitis B virus in Indonesia: identification of two novel subgenotypes, B8 and C7. Arch Virol 2009;154(7):1047–1059

    Article  CAS  PubMed  Google Scholar 

  18. Jameson BA, Wolf H. The antigenic index: a novel algorithm for predicting antigenic determinants. Cabios 1988;4:181–186

    CAS  PubMed  Google Scholar 

  19. Ghany MG, Ayola B, Villamil FG, Gish RG, Rojter S, Vierling JM, Lok AS. Hepatitis B Virus mutants in liver transplant recipients who were reinfected despite Hepatitis B Immune Globulin prophylaxis. Hepatology 1998;27:213–221

    Article  CAS  PubMed  Google Scholar 

  20. Stuvyer LJ, Locarnini SA, Lok A, Richman DD, Carman WF, Dienstag JL, Schinazi RF. The HEP DART IC. Nomenclature for antiviral-resistant human Hepatitis B Virus mutations in the polymerase region. Hepatology 2001;33:751–757

    Article  Google Scholar 

  21. Wang JT, Lee CZ, Chen PJ, Wang TH, Chen DS. Transfusion-transmitted HBV infection in an endemic area: the necessity of more sensitive screening for HBV carriers. Transfusion 2002;42:1592–1517

    Article  PubMed  Google Scholar 

  22. Khan M, Dong JJ, Acharya SK, Dhagwahdorj Y, Abbas Z, Jafri SMW, Mulyono DH, Tozun N, Sarin SK. Hepatology issues in Asia: perspectives from regional leaders. J Gastroenterol Hepatol 2004;19:S419–S430

    Article  Google Scholar 

  23. Owusu-Ofori S, Temple J, Sarkodie F, Anokwa M, Candotti D, Allain JP. Predonation screening of blood donors with rapid test: implementation and efficacy of a novel approach to blood safety in resource-poor settings. Transfusion 2005;45:133–140

    Article  PubMed  Google Scholar 

  24. Yotsuyanagi H, Yasuda K, Moriya K, Shintani Y, Fujie H, Tsutsumi T, Nojiri N, Juji T, Hoshino H, Shimoda K, Hino K, Kimura S, Iino S, Koike K. Frequent presence of HBV in the sera of HBsAg-negative, anti-HBc-positive blood donors. Transfusion 2001;41(9):1093–1099

    Article  CAS  PubMed  Google Scholar 

  25. El-Sherif AM, Abou-Shady MA, Al-Hiatmy MA, Al-Bahrawy AM, Motawea EA. Screening for hepatitis B virus infection in Egyptian blood donors negative for hepatitis B surface antigen. Hepatol Int 2007;1:469–470

    Article  PubMed  Google Scholar 

  26. Hollinger FB. Hepatitis B virus infection and transfusion medicine: science and the occult. Transfusion 2008;48:1001–1026

    Article  CAS  PubMed  Google Scholar 

  27. Niederhauser C, Taleghani BM, Graziani M, Stolz M, Tinguely C, Schneider P. Blood donor screening: how to decrease the risk of transfusion-transmitted hepatitis B virus? Swiss Med Wkly 2008;138(9–10):134–141

    PubMed  Google Scholar 

  28. Matsumoto C, Tadokoro K, Fujimura K, Hirakawa S, Mitsunaga S, Juji T. Analysis of HBV infection after blood transfusion in Japan through investigation of a comprehensive donor specimen repository. Transfusion 2001;41:878–884.

    Google Scholar 

  29. Ho MS, Mau YC, Lu CF, Huang SF, Hsu LC, Lin SR, Hsu HM. Patterns of circulating hepatitis B surface antigen variants among vaccinated children born to hepatitis B surface antigen carrier and non-carrier mothers: a population-based comparative study. J Biomed Sci 1998;5:355–362

    Article  CAS  PubMed  Google Scholar 

  30. Hou JL, Wang ZH, Cheng JJ, Lin YL, Lau GKK, Sun J, Zhou FY, Waters J, Karayiannis P, Luo KX. Prevalence of naturally occuring surface gene variants of hepatitis B virus in non-immunized surface antigen-negative Chinese carriers. Hepatology 2001;34:1027–1034

    Article  CAS  PubMed  Google Scholar 

  31. Thakur V, Kazim SN, Guptan RC, Hasnain SE, Bartholomeusz A, Malhotra V, Sarin SK. Transmission of G145R mutant of HBV to an unrelated contact. J Med Virol 2005;76:40–46

    Article  PubMed  Google Scholar 

  32. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990;336:325–329

    Article  CAS  PubMed  Google Scholar 

  33. Seddigh-Tonekaboni S, Waters JA, Jeffers S, Gehrke R, Ofenloch B, Horsch A, Hess G, Thomas HC, Karayiannis P. Effect of variation in the common “a” determinant on the antigenicity of hepatitis B surface antigen. J Med Virol 2000;60:113–121

    Article  CAS  PubMed  Google Scholar 

  34. Zuckerman AJ. Effect of hepatitis B virus mutants on efficacy of vaccination. Lancet. 2000;355:1382–1383

    Article  CAS  PubMed  Google Scholar 

  35. Radziwill G, Tucker W, Schaller H. Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity. J Virol 1990;64(2):613–620

    CAS  PubMed  Google Scholar 

  36. Torresi J, Earnest-Silveira L, Civitico G, Walters TE, Lewin SR, Fyfe J, Locarnini SA, Manns M, Trautwein C, Bock TC. Restoration of replication phenotype of lamivudine-resistant hepatitis B virus mutants by compensatory changes in the “Fingers” subdomain of the viral polymerase selected as a consequence of mutations in the overlapping S gene. Virology 2002;299:88–99

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Eijkman Institute for Molecular Biology, Jl. Diponegoro 69, Jakarta, Indonesia

    Meta D. Thedja, Martono Roni, Alida R. Harahap, Nurjati C. Siregar, Susan I. Ie & David H. Muljono

  2. Faculty of Medicine, University of Indonesia, Jl. Salemba 6, Jakarta, Indonesia

    Alida R. Harahap & Nurjati C. Siregar

Authors
  1. Meta D. Thedja
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Martono Roni
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alida R. Harahap
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nurjati C. Siregar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Susan I. Ie
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. David H. Muljono
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David H. Muljono.

Additional information

An erratum to this article can be found at http://dx.doi.org/10.1007/s12072-010-9212-4

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thedja, M.D., Roni, M., Harahap, A.R. et al. Occult hepatitis B in blood donors in Indonesia: altered antigenicity of the hepatitis B virus surface protein. Hepatol Int 4, 608–614 (2010). https://doi.org/10.1007/s12072-010-9203-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12072-010-9203-5

Keywords

Search

Navigation